Commercial Grant and Speaker Control in a CME Conference
A nonprofit CME provider is planning a one-day regional conference on type 2 diabetes. A pharmaceutical company offers a $75,000 educational grant. The company's letter lists conditions: it must approve the final speaker list; it wants to review all slides two weeks before the event; two sales representatives will staff the registration desk; the company logo will appear on the syllabus cover; and a 10-minute product theater will run in the same hall during the lunch break. The provider is ACCME-accredited and has already received the grant check. The course director says the company 'has been supportive for years' and that rejecting the conditions may lose future funding. The provider's compliance committee meets tomorrow. No written letter of agreement has been signed, and the company has not completed a financial-relationship disclosure.
1. Evaluate the company's conditions against ACCME independence requirements. Which conditions are acceptable and which are not?
Read the worked answer
The conditions are inconsistent with ACCME independence. The provider, not the company, must control speaker selection, content, and evaluation. A commercial supporter cannot approve the speaker list or review slides before the event; that is content control. Sales representatives staffing the registration desk blurs promotion and education and is not acceptable in the CME space. The company logo on the syllabus cover may imply control or endorsement; acknowledgment of commercial support should be limited and neutral. The product theater may be allowed only if it is clearly promotional, separate from the CME activity, not in the same hall during CME, and not eligible for CME credit. The $75,000 grant must be documented in a signed letter of agreement. The provider also needs disclosure and mitigation of financial relationships.
2. What should the provider do before signing anything or using the grant funds?
Read the worked answer
I would not sign the company's letter as written. The provider should hold or return the check until a proper letter of agreement is signed that states the grant is unrestricted and the company has no control over content. The provider should select speakers, require disclosures, mitigate conflicts, and keep all promotional activity out of CME sessions. If the company insists on slide review or registration staffing, the provider should decline the grant. The product theater should be moved to a separate room and time and clearly labeled as promotional; it cannot be included in CME credit. The syllabus should acknowledge support in a neutral way, not with a logo that suggests sponsorship control. The provider must document the commercial support and any in-kind support.
3. What additional ACCME and disclosure issues should the compliance committee examine?
Read the worked answer
The provider should also check whether the company is an ineligible company and whether any planners or speakers have relevant financial relationships. Those relationships must be disclosed to learners and mitigated before the activity. The provider should not let the company's sales team collect attendee names for promotional follow-up in the CME area. If the product theater is retained, attendance should be separate and not counted as CME. The provider should keep the grant accounting separate and ensure the total commercial support is disclosed. If the company will not accept these conditions, the safest course is to return the grant and seek other support.